Пошук по сайту

Авторизація

Періодика

Партнери

Поиск информации по диагнозу / Med And Me

Технічна підтримка

Тканинна інженерія та трансплантація клітин: американські ринки приладів сечостатевої системи (Tissue Engineering and Cell Transplantation: U.S. Markets for Urogenital Products)

This new report from Medtech Insight analyzes the potential United States (U.S.) market for tissue engineering products for urogenital indications. This market is projected to be substantial, reaching an estimated $9.1 billion in the year 2019, based on a potential caseload of 2.2 million patients.

Market segments covered by this report include tissue engineering and cell transplantation products for bladder repair and replacement, incontinence treatment, penile replacement and prostheses, and urethral augmentation. A variety of tissue engineering approaches show promise for treating diseases and disorders of the urogenital system including cell-based gene therapy, growth factors, injectable scaffolds, stem cell therapy, and tissue-engineered bladders, ureters, and ureteral segments.

The clinical overview section of this report provides a synopsis of selected urogenital diseases and disorders including up-to-date incidence and prevalence numbers for each.

This report is the fourth in a series of six Medtech Insight reports covering U.S. tissue engineering markets. Upcoming reports in this series will provide analyses of U.S. markets for tissue-engineered organ regeneration and skin replacement products.

TABLE OF CONTENTS

EXECUTIVE SUMMARY

i. Selected Urogenital Diseases and Disorders

a. Bladder Cancer
b. Erectile Dysfunction
c. Prostate Cancer
d. Urinary Incontinence

ii. Existing Therapies

a. Bladder, Ureteral, and Urethral Repair
b. Incontinence Treatment
c. Penile Prostheses
d. Vesicoureteral Reflux Treatment

iii. Tissue Engineering Technologies

a. Biomaterials
b. Cell Culture Technology
c. Stem Cell Technology
d. Immunoisolation Technology

iv. U.S. Markets for Urogenital Tissue Engineering and Cell Transplantation Products

a. Bladder Repair and Replacement
b. Gene Therapy
c. Reconstituted Structures
d. Ureteral and Urethral Repair and Replacement
e. Urethral Augmentation
f. Market Analysis

v. Methodology

Exhibit ES-1: Tissue Engineering and Cell Transplantation Products for Urogenital Applications, Potential Market Forecast, 2009 and 2019

1. OVERVIEW OF SELECTED UROGENITAL DISEASES AND DISORDERS

1.1 Selected Urogenital Diseases and Disorders

1.1.1 Bladder Cancer
1.1.2 Erectile Dysfunction
1.1.3 Prostate Cancer
1.1.4 Urinary Incontinence

1.2 Existing Therapies

1.2.1 Bladder, Ureteral, and Urethral Repair
1.2.2 Incontinence Treatment
1.2.3 Penile Prostheses
1.2.4 Vesicoureteral Reflux Treatment

Exhibit 1-1: 2009, Incidence and Prevalence of Urogenital Diseases and Disorders Potentially Treatable Using Tissue Engineering
Exhibit 1-2: Bladder Cancer, Facts and Figures
Exhibit 1-3: Erectile Dysfunction, Facts and Figures
Exhibit 1-4: Prostate Cancer, Facts and Figures
Exhibit 1-5: Urinary Incontinence, Facts and Figures
Exhibit 1-6: Types of Urinary Incontinence
Exhibit 1-7: 2009, Urogenital Treatments, Procedure Volumes

2. TISSUE ENGINEERING AND ORGAN REGENERATION TECHNOLOGIES

2.1 Biomaterials

2.1.1 Synthetic Biomaterials
2.1.2 Biologically Derived Biomaterials

2.1.2.1 Collagen
2.1.2.2 Xenogeneic Tissue

2.1.3 Hybrid Biomaterials
2.1.4 Genetically Engineered Biomaterials

2.1.4.1 Deoxyribonucleic Acid Transfection Vectors
2.1.4.2 Genetically Manipulated Cells
2.1.4.3 Three-Dimensional Polymer Technology
2.1.4.4 Transgenics
2.1.4.5 Fibroblasts
2.1.4.6 Immortalized Neural Stem Cells
2.1.4.7 Gene-Activated Matrices

2.1.5 Scaffolds
2.1.6 Vascular Grafts

2.2 Cell Culture Technology

2.2.1 Bioreactors

2.2.1.1 Flatbed Perfusion Systems
2.2.1.2 Hollow Fiber Bioreactor Systems
2.2.1.3 Cell Suspension Systems
2.2.1.4 Disposable Bioreactors

2.3 Stem Cell Technology

2.3.1 Cell Extraction and Expansion
2.3.2 Bioreactors

2.4 Immunoisolation Technology

2.4.1 Chimeric Immunity
2.4.2 Cell Encapsulation Technology

Exhibit 2-1: 2010, Selected Synthetic Biomaterials Used in Tissue Engineering
Exhibit 2-2: 2010, Selected Natural Biomaterials Used in Tissue Engineering
Exhibit 2-3: 2010, Selected Current and Emerging Cell Extraction, Expansion, and Separation Products and Technologies

3. U.S. MARKETS FOR UROGENITAL TISSUE ENGINEERING AND CELL TRANSPLANTATION PRODUCTS

3.1 Biomaterials
3.2 Bladder Repair and Replacement

3.2.1 Tengion

3.3 Gene Therapy Products

3.3.1 Ion Channel Innovations

3.4 Reconstituted Structures
3.5 Ureteral and Urethral Repair and Replacement Products

3.5.1 C.R. Bard
3.5.2 Boston Scientific
3.5.3 Cook Biotech/Cook Group
3.5.4 Innovacell Biotechnologie
3.5.5 Tengion

3.6 Urethral Augmentation Products

3.6.1 C.R. Bard
3.6.2 Boston Scientific
3.6.3 Oceana Therapeutics
3.6.4 Uroplasty

3.7 Market Analysis

3.7.1 Market Drivers
3.7.2 Market Limiters

3.8 Competitive Analysis

Exhibit 3-1: 2010, Selected Tissue Engineering and Cell Transplantation Products for Urogenital Applications
Exhibit 3-2: Tissue Engineering and Cell Transplantation Products for Urogenital Applications, Potential Market Forecast, 2009 and 2019
Exhibit 3-3: Tissue Engineering and Cell Transplantation Technologies for Urogenital Applications, by Indication, 2009 and 2019
Exhibit 3-4: Tissue Engineering and Cell Transplantation Products for Urogenital Applications, Product Introduction Forecast, 2014 and 2019

4. COMPANY PROFILES

4.1 C.R. Bard, Inc.
4.2 Boston Scientific Corporation
4.3 Cook Group, Inc.
4.4 Innovacell Biotechnologie AG
4.5 Ion Channel Innovations LLC
4.6 LifeCell Corporation/Kinetic Concepts, Inc.
4.7 Merz Pharmaceuticals, Inc.
4.8 Q-Med AB
4.9 TEI Biosciences, Inc.
4.10 Tengion, Inc.
4.11 Uroplasty, Inc.

Publisher: Medtech Insight
Перекладач: translate.google.com

Новини

19.10.2018  Японці випробують клітинні технології на жертвах хвороби Паркінсона
19.10.2018  Дослідники протестували новий засіб проти облисіння і старіння шкіри
19.10.2018  Вчені: світова епідемія нового вірусу - цілком реальна загроза
19.10.2018  Як уберегтися від онкологічних захворювань, рекомендації
19.10.2018  Онкологи представили нестандартний підхід в лікуванні раку
18.10.2018  Вчені наблизилися до отримання штучного серця
18.10.2018  Хірурги навчилися швидко заліковувати переломи хребта
18.10.2018  Дослідники заявляють: ліки проти наркоманії знайдено
18.10.2018  Генетики пролили світло на причини розвитку хвороби Паркінсона
18.10.2018  Зараження паразитами змушує людей йти на ризик
17.10.2018  Генетики: є інструменти, що дозволяють перемогти вроджені недуги
17.10.2018  Хірурги змогли прооперувати мозок дитини, що знаходиться в утробі
17.10.2018  Новий клітинний імплантат замінить підшлункову у діабетиків
17.10.2018  Нюх і система формування спогадів виявилися тісно пов'язані
17.10.2018  Метабоцин - новий засіб, який допоможе впоратися з ожирінням
16.10.2018  У грибах на Далекому Сході знайшли протиракові з'єднання
16.10.2018  Дослідники перетворили популярну спецію в ліки від глаукоми
16.10.2018  Неврологи виявили зв'язок розсіяного склерозу і заліза
16.10.2018  Вчені розвінчали міф про безпеку рослинного наркотику
16.10.2018  Вчені: клітини шкіри старіють через проблеми з їх "енергетичними фабриками"